| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3092934 | Surgical Neurology | 2008 | 4 Pages |
Abstract
Based on our study, the patients of malignant glioma treated with radiotherapy followed by temozolomide obtained a statistically significant better benefit of survival than those treated with radiotherapy alone. Temozolomide therapy was well tolerated by the patients. The larger series of patients and long-term follow-up of late toxic effects are needed for further confirmation.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tzu-Ming MD, Hung-Chen MD, Yu-Jun MD, Wei-Che MD, Cheng-Hsien MD, Wen-Neng MD, Hsueh-Wen PhD, Jih-Tsun MD, PhD,